v3.26.3
FINANCIAL INSTRUMENTS - Schedule of Investments Without Readily Determinable Fair Value (Details) - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2026
Dec. 31, 2025
Feb. 28, 2025
Investments Without Readily Determinable Fair Value Roll Forward [Abstract]      
Beginning balance $ 10,250 $ 27,775  
Purchases   1,250  
Impairments   (11,000)  
Realized gain of prior investments   5,863  
Settled investments   (13,599)  
Foreign currency adjustments   (39)  
Asset, period increase (decrease) 0    
Ending balance 10,250 10,250  
GQ Bio Therapeutics GmbH      
Investments Without Readily Determinable Fair Value Roll Forward [Abstract]      
Percentage of voting interests acquired     81.00%
GQ Bio Therapeutics GmbH | GQ Bio Therapeutics GmbH      
Investments Without Readily Determinable Fair Value Roll Forward [Abstract]      
Percentage of voting interests acquired     81.00%
Equity Investments      
Investments Without Readily Determinable Fair Value Roll Forward [Abstract]      
Beginning balance 7,750 15,877  
Purchases   0  
Impairments   (4,000)  
Realized gain of prior investments 4,200 4,189  
Settled investments   (8,277)  
Foreign currency adjustments   (39)  
Asset, period increase (decrease) 0    
Ending balance 7,750 7,750  
Convertible Notes Receivable      
Investments Without Readily Determinable Fair Value Roll Forward [Abstract]      
Beginning balance 2,500 11,898  
Purchases   1,250  
Impairments   (7,000)  
Realized gain of prior investments 1,700 1,674  
Settled investments   (5,322)  
Foreign currency adjustments   0  
Asset, period increase (decrease) 0    
Ending balance $ 2,500 $ 2,500